Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01239901 · ClinicalTrials.gov registry record
Iron Mediated Vascular Disease in Sickle Cell Anemia Patients
A clinical trial, sponsored by Children's Hospital Los Angeles.
- Completed
- Registry status
- 150
- Enrollment target
NCT01239901 is a clinical trial that has completed, run by Children's Hospital Los Angeles. The registered enrollment target is 150 participants.
The verdict
NCT01239901 has completed, sponsored by Children's Hospital Los Angeles.
- COMPLETED
- Registry status
- 150 participants
- Enrollment target
Study Summary
The purpose of this research study is to determine the frequency and severity of iron overload in patients with Sickle Cell Anemia and its relationship to blood vessel function. The investigators hypothesize that intermittent transfusions that these patients receive during hospitalizations produces significant iron overload and impairs blood vessel relaxation.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2009-12 |
| Est. Completion | 2018-10 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01239901
The ClinicalTrials.gov registry entry for NCT01239901 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Children's Hospital Los Angeles, which has 119 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01239901 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01239901 about?
NCT01239901 is a clinical study titled "Iron Mediated Vascular Disease in Sickle Cell Anemia Patients". The purpose of this research study is to determine the frequency and severity of iron overload in patients with Sickle Cell Anemia and its relationship to blood vessel function. The investigators hypothesize that intermittent transfusions that these patients receive during hospitalizations produces ...
What is the current status of trial NCT01239901?
This trial is currently completed. The enrollment target is 150 participants. The study started on 2009-12. Estimated completion is 2018-10.
Who is sponsoring clinical trial NCT01239901?
This trial is sponsored by Children's Hospital Los Angeles, which has 119 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.